Mgr. Veronika Navrkalová, Ph.D.
Senior researcher, Šárka Pospíšilová Research Group
Office: bldg. E35/218
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7945 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 115
2015
-
Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
Year: 2015, type: Conference abstract
-
Molekulární prognostické markery chronické lymfocytární leukemie a jejich klinický význam
Klinická onkologie, year: 2015, volume: 28, edition: Suppl 3, DOI
-
Mutační a funkční analýza genu ATM u pacientů s chronickou lymfocytární leukémií
Year: 2015, type: Conference abstract
-
Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients
Haematologica, year: 2015, volume: 100, edition: 8, DOI
-
Prognostický význam hot spot mutace genu NOTCH1 u pacientů s chronickou lymfocytární leukemií a souvislosti s molekulárně biologickými markery onemocnění
Year: 2015, type: Conference abstract
-
Prognostický význam NOTCH1 murací u chronické lymfocytární leukemie.
Year: 2015, type:
-
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
Leukemia, year: 2015, volume: 29, edition: 2, DOI
-
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation within a clinical setting
Haematologica, year: 2015, volume: 100, edition: 3, DOI
-
The impact of SF3B1 mutations in CLL on the DNA-damage response
Leukemia, year: 2015, volume: 29, edition: 5, DOI
2014
-
Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab
Experimental Hematology, year: 2014, volume: 42, edition: 10, DOI